The SANUKEHL
Preparations -
Polysaccharides for Haptenic
Therapy
by
Peter Schneider
ã Copyright 1998 by Semmelweis-Verlag, D-27318 Hoya, Germany
(see also Isopathic/Homeopathic Materia Medica)
Disclaimer:
It is the purpose of this book to inform about the use of SANUKEHL preparations for a wide range of medical problems. However, illness can be highly unpredictable, and the best possible expertise should always be consulted. The authors and the publishers accept no liability for any claims arising from the use of any remedy or strategy discussed here.
Contents
Introduction
Production of SANUKEHLs
Using Sanukehls
Sanukehl Preparations
References
For many diseases, a pathogens toxins can still be present after the germ itself has been eliminated, thus perpetuating the disease. In fact, the toxins might be the sole disease-causing agent. To protect themselves from their own toxins, pathogens produce specific polysaccharides (termed antigen absorbers by CORNELIUS) designed to bind the pathogens own toxins or antigens, preventing them from becoming active. Moreover, viruses, bacteria, plants and animals know how to store and communicate information with the aid of saccharides. The code laid down in this language is thus able to influence a multitude of regulatory processes in the host organism.
Furthermore, the low-molecular-weight polysaccharides represent haptens, which when coupled to a higher-molecular-weight carrier (e.g. protein) can stimulate cellular and humoral defenses. Bacterial toxins released during earlier infections and not eliminated from the body due to immune-system deficiencies can be bound by haptens, and thus represent an antigen. This antigen is capable of stimulating the immune system by activating the T lymphocytes, ultimately leading to elimination of the bacterial toxins.
The initial materials for the various SANUKEHLs are dead cells of the corresponding bacterial or fungal types. Using a painstaking extraction process, the polysaccharides necessary for haptenic therapy are dissolved out of the organisms cell walls. Due to differences in the fine structure of these polysaccharides in each bacterial or fungal type, this results in a large number of antigen variations.
In the extractions process, the polysaccharides are separated out from undesired proteins, as well as from lipid A, which is also a cell-wall component in gram-negative bacteria. The proteins could trigger an allergic reaction, while lipid A is responsible for the toxic effect of the lipopolysaccharides (endotoxins) of gram-negative bacteria.
Polysaccharides from microorganisms are nontoxic to the host organism. For haptenic therapy with SANUKEHLs, the extracted polysaccharide extract is homeopathically potentiated; the end result is largely free of proteins and endotoxins. Therefore, allergic and fever reactions to the use of SANUKEHLs are unlikely.
The following haptens are available as SANUKEHL Preparations in homeopathic dilutions:
SANUKEHLâ ACNE D6 Drops (Propionibacterium acnes)
SANUKEHLâ BRUCEL D6 Drops (Brucella melitensis)
SANUKEHLâ CAND D6 Drops (Candida albicans)
SANUKEHLâ COLI D6 Drops (Escherichia coli)
SANUKEHLâ COLI D7 Injection (Escherichia coli)
SANUKEHLâ KLEBS D6 Drops (Klebsiella pneumoniae)
SANUKEHLâ MYC D6 Drops (Mycobacterium bovis (BCG))
SANUKEHLâ PROT D6 Drops (Proteus vulgaris)
SANUKEHLâ PSEU D6 Drops (Pseudomonas aeruginosa)
SANUKEHLâ SALM D6 Drops (Salmonella enteritidis)
SANUKEHLâ SERRA D6 Drops (Serratia marcescens)
SANUKEHLâ STAPH D6 Drops (Staphylococcus aureus)
SANUKEHLâ STREP D6 Drops (Streptococcus pyogenes)
SANUKEHLâ TRICH D6 Drops (Trichophyton verrucosum)
Except for SANUKEHLâ COLI D7, SANUKEHL injection preparations are not yet registered in Germany. Also SANUKEHLâ SERRA D6 Drops are not registered in this country.
Because of their effect in the organism, the SANUKEHL Preparations are utilized in the following areas:
1. Specific Terrain Cleansing
SANUKEHL Preparations are no nosodes. Specific terrain cleansing of microorganisms or their metabolic products is possible with the aid of the SANUKEHL Preparations in conjunction with microbiological or mycological findings. In addition, the corresponding SANUKEHLs be used against infections with similar pathogens.
Administering specific polysaccharides communicates specific information to the host organism which it needs to regulate its symbiontic equilibrium with the microorganisms in question.
2. Modulating the Immune System and Eliminating Reaction Blockages
After binding to a carrier molecule in the organism, haptens can trigger a humoral as well as a cellular immune response. These mechanisms neutralize and eliminate microbial antigens. Introducing the SANUKEHL structures to the body very quickly leads to immune-complex formation using the immunoglobulins present. This substance presumably functions as an immune modulator which effects a correction of immune-regulatory imbalances and develops its effect, for example, via induction of cytokines, particularly GM-CSF and IL-10. Based on investigations into the effects of SANUKEHL Pseu, it was possible to derive, in an immunologically substantiatable manner, that long-lasting reaction blockages (e.g. as a consequence of treatment with corticosteroids) in cancer patients, or in cases of immune-system suppression, can be eliminated with the aid of the modulating effect of SANUM Pharmaceuticals.
3. Hyposensitization
Haptens can also bind the antibodies or circulating immune complexes created to counteract the corresponding complete antigen. These antibodies (IgG) exhibit a blocking activity to allergic reactions that is transmitted by another antibody class (IgE). As hyposensitization continues to develop, the proportion of IgG often increases, while the concentration of IgE in the blood serum falls off.
4. Intermediate Agents when Treating with Nosodes
This effect is based on the absorption of the pathogenic antigens or toxins. Severe initial deterioration or antigen blockages are alleviated or eliminated by SANUKEHL Preparations.
5. As a Pharmaceutical for Individual
Clinical Indication
(see also Isopathic/Homeopathic Materia
Medica)
Usage (Drops): Take for acute conditions, 510 drops every 1224 hours; for chronic illnesses, 10 drops every other day.
As an embrocation: 510 drops every 1 or 2 days at the site of the disease or in the bend of the elbow. After 8 months, therapy should be discontinued for several months.
Usage (injections): Inject 1 ml s.c. 13 times per week
Side effects: The presence of certain specific organic
components can, in rare cases, trigger hypersensitivity reactions.
Active agent: Propionibacterium acnes
Nosode: Corynebacterium anaerobium
Naturopathically documented areas of application:
Acne conglobata, rheumatoid arthritis
Active agent: Brucella melitensis
Nosode: Brucella abortus
Naturopathically documented areas of application:
Myalgia, subacute rheumatoid arthritis, intermittent fever
Active agent: Candida albicans
Nosode: Monilia albicans
Naturopathically documented areas of application:
Oral diseases (stomatitis, gingivitis, perlèche, aphthous ulcers),
spasmodic painful small intestine, colitis, constipation after
treatment with antibiotics, allergic asthma, inflammation of the
vulva, vulvovaginitis, Craurosis vulvae, rectilinear fissural
skinfold or mucous-membrane eczema, interdigital eczema of the
hands or feet, dermatosis after treatment with antibiotics
SANUKEHLÒ Coli D7 Injection
Active agent: Escherichia coli
Nosode: Bac. coli
Naturopathically documented areas of application:
Cholangitis, cholecystitis, gastroenteritis, colitis,
pyelonephritis, spermatocystitis, epididymitis, cystitis,
prostatitis, salpingitis, metritis, vaginitis
Active agent: Klebsiella pneumoniae
Nosode: Klebsiella pneumoniae
Naturopathically documented areas of application:
For supportive therapy during or after Friedländers
pneumonia; in cases of silicosis, pneumoconiosis, bronchiectasis,
bronchial asthma; as an adjuvant in cases of acute influenza,
pleuritis, pneumonia; for therapeutic injury after antibiotic
therapy
Active agent: Mycobacterium bovis
Nosode: B.C.G.
Naturopathically documented areas of application:
Aphonia, bronchial asthma, cardiac arrhythmia, arthritis,
juvenile acne, cholecystitis, cystopyelitis, eczema with fissures,
enterocolitis, hordeolum, hydrocele, conjunctivitis, keratitis,
headaches, laryngeal ulcer, cardialgia, Lupus erythematodes,
metritis, nephritis, otitis, osteochondrosis, pleuritis,
psoriasis, rhinitis, ventricular or duodenal ulcers, urticaria
Active agent: Proteus vulgaris
Nosode: Bac. proteus
Naturopathically documented areas of application:
Gastroenteritis, peritonitis, cystopyelitis, puerperal sepsis,
otitis, gangrenous pulmonary processes, osteomyelitis, abnormal
intestinal bacterial flora after antibiotic therapy, peripheral
circulatory disorders, ventricular or duodenal ulcers,
hematemesis, angio-neurotic edema, Menières disease,
herpes
Active agent: Pseudomonas aeruginosa
Nosode: Bac. pyocyaneus
Naturopathically documented areas of application:
Infectious and allergic dermatitis, pruritus, insect bites,
angioneurotic edema, collagen disease, arthropathic fibrositis,
keloids, Ulcus cruris, burns, bronchial asthma, otitis, sinusitis,
pharyngitis, chronic bronchitis, hay fever
Active agent: Salmonella enteritidis
Nosode: Bac. gärtner
Naturopathically documented areas of application:
Growth inhibition, chronic pancreatitis, enterobiasis (oxyuriasis),
chronic gastroenteritis, celiac disease, furunculosis, rheumatic
fever
Active agent: Serratia marcescens
Nosode: Enterococcinum
Naturopathically documented areas of application:
In nosocomial infections with Serratia marcescens
Active agent: Staphylococcus aureus
Nosode: Staphylococcus aureus
Naturopathically documented areas of application:
Folliculosis, furunculitis, impetigo, blepharitis, hordeolum,
tarsal cyst, angina, otitis, sinusitis, mastoiditis, meningitis,
osteomyelitis, nephritis, urogenital staphylococcal infections
Active agent: Streptococcus pyogenes
Nosode: Streptococcinum
Naturopathically documented areas of application:
Alopecia, Angina tonsillaris, cardialgia, eczema, endocarditis,
myocarditis, pericarditis, empyema, puerperal mastitis, migraine,
osteomyelitis, Otitis media, phlegmon, chronic rheumatoid
arthritis
Active agent: Trichophyton verrucosum
Nosode: Trichophytosis
Naturopathically documented areas of application:
Mycoses of the hairs, skin, nails; tinea, trichophytosis; impairment of skin
function, hair loss
Al-Haj, M. (1997): Pictures confirm therapeutic success.
Using agents of a homeopathic-isopathic product line from
Germany in clinical practice against Alopecia areata.
Explore! 8 (3), 24-25
Hartmann, J. (1998): The Pleo preparation PleoÔ San Brucel its action principle Brucella melitensis in therapy. Explore! 8 (6), 24
Kunze, R. and J. Hartmann (1997): Eliminating hydrocortisone-induced immune suppression with Pseudomonas aeruginosa in vitro (1). Explore! 8 (2), 8
Kunze, R. and J. Hartmann (1997): Eliminating hydrocortisone-induced immune suppression with Pseudomonas aeruginosa in vitro (2). Explore! 8 (3), 3-7
Schneider, P. (1998): The status of the PleoÔ Sans in Pleo Therapy extension of biological regulation therapy. Explore! 8 (5), 19-20
Werthmann, K. (1998): Experiences in the therapy of
rheumatoid arthritis using haptens
extracted from Propionibacterium acnes. Explore! 8
(5), 5
Werthmann, K. (1998): Masked nosocomial infections as
possible causes of "feverish"
infections. Explore! 8 (3), 6-7